LIEU HSIAO D (SVP, Chief Medical Officer) received a stock award from NGM BIOPHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/6/2023ACC: 0001209191-23-016392
Officer· SVP, Chief Medical Officer
Since Mar 2020
+212K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
212K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+53K
Price / share
—
Trade value
—
% of position
2034.5%
3/2/2023
2.60K→55.60K
Total
Net shares
+53K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2023 | A · Award | +53K | — | — | 2034.5% | 2.60K | 55.60K |
| Total | +53K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
159K shares
Shares
+159K
Strike price
4.36
Held after
159K
Exercisable
—
3/2/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock159K shares | 3/2/2023 | A · Award | +159K | 4.36 | — | 159K |